DB

Danna Breen

Research Fellow at Pfizer

Danna Breen is an accomplished researcher currently serving as a Senior Principal Scientist at Pfizer, where responsibilities include investigating novel obesity drug targets since October 2012. Prior experience includes a Postdoctoral Fellowship at University Health Network from August 2010 to September 2012, focused on gut nutrient sensing mechanisms and their role in glucose homeostasis related to bariatric surgery. Danna Breen earned a Doctor of Philosophy (PhD) in Physiology from the University of Toronto, where research centered on insulin and resveratrol's effects on restenosis and atherosclerosis. Academic qualifications also include a Master's degree and Bachelor's degree in Health Services from Brock University.

Location

Cambridge, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


P

Pfizer

601 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.